Large Randomized Trial Finds Proton Therapy Offers No Survival Advantage in Advanced Liver Cancer
The Phase III NRG-GI003 trial was stopped early for futility after proton therapy failed to improve overall survival compared with ...
The Phase III NRG-GI003 trial was stopped early for futility after proton therapy failed to improve overall survival compared with ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.